These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30418050)

  • 21. Pragmatic trials revisited: applicability is about individualization.
    Sacristán JA; Dilla T
    J Clin Epidemiol; 2018 Jul; 99():164-166. PubMed ID: 29432859
    [No Abstract]   [Full Text] [Related]  

  • 22. Series: Pragmatic trials and real world evidence: Paper 7. Safety, quality and monitoring.
    Irving E; van den Bor R; Welsing P; Walsh V; Alfonso-Cristancho R; Harvey C; Garman N; Grobbee DE;
    J Clin Epidemiol; 2017 Nov; 91():6-12. PubMed ID: 28502812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leveraging electronic health record data for pragmatic randomized trials.
    Roe MT
    Clin Trials; 2020 Aug; 17(4):368-369. PubMed ID: 32668979
    [No Abstract]   [Full Text] [Related]  

  • 24. Exploring the pragmatic and explanatory study design on outcomes of systematic reviews of public health interventions: a case study on obesity prevention trials.
    Yoong SL; Wolfenden L; Clinton-McHarg T; Waters E; Pettman TL; Steele E; Wiggers J
    J Public Health (Oxf); 2014 Mar; 36(1):170-6. PubMed ID: 24574064
    [No Abstract]   [Full Text] [Related]  

  • 25. Series: Pragmatic trials and real world evidence: Paper 6. Outcome measures in the real world.
    Welsing PM; Oude Rengerink K; Collier S; Eckert L; van Smeden M; Ciaglia A; Nachbaur G; Trelle S; Taylor AJ; Egger M; Goetz I;
    J Clin Epidemiol; 2017 Oct; 90():99-107. PubMed ID: 28502810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pragmatic clinical trials at the National Institute of Nursing Research.
    Littleton-Kearney M
    Nurs Outlook; 2018 Sep; 66(5):470-472. PubMed ID: 29699773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommendations for the design of Phase 3 pharmaceutical trials that are more informative for patients, clinicians, and payers.
    Sonnad SS; Mullins CD; Whicher D; Goldsack JC; Mohr PE; Tunis SR
    Contemp Clin Trials; 2013 Nov; 36(2):356-61. PubMed ID: 23999501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What's the uptake? Pragmatic RCTs may be used to estimate uptake, and thereby population impact of interventions, but better reporting of trial recruitment processes is needed.
    Bell KJL; McCullough A; Del Mar C; Glasziou P
    BMC Med Res Methodol; 2017 Dec; 17(1):174. PubMed ID: 29272994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulary restrictions may impact enrollment in pragmatic trials and limit generalizability of findings to vulnerable populations.
    Segal JB;
    Clin Trials; 2020 Dec; 17(6):729-731. PubMed ID: 32650667
    [No Abstract]   [Full Text] [Related]  

  • 30. The cohort multiple randomized controlled trial design: a valid and efficient alternative to pragmatic trials?
    van der Velden JM; Verkooijen HM; Young-Afat DA; Burbach JP; van Vulpen M; Relton C; van Gils CH; May AM; Groenwold RH
    Int J Epidemiol; 2017 Feb; 46(1):96-102. PubMed ID: 27118559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Knowledge of health outcomes generated by drugs in the real world: Temporary fashion or real need?].
    Soto Álvarez J
    Med Clin (Barc); 2015 Dec; 145(12):535-8. PubMed ID: 26143947
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of Pragmatism in Recently Published Randomized Clinical Trials.
    Janiaud P; Dal-Ré R; Ioannidis JPA
    JAMA Intern Med; 2018 Sep; 178(9):1278-1280. PubMed ID: 30039169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pragmatism in practice: lessons learned during screening and enrollment for a randomised controlled trial in rural northern Ethiopia.
    Molla M; Negussie H; Ngari M; Kivaya E; Njuguna P; Enqueselassie F; Berkley JA; Davey G
    BMC Med Res Methodol; 2018 Mar; 18(1):26. PubMed ID: 29514613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trial methodology to assess the efficacy/effectiveness of long-acting antipsychotics: Randomized controlled trials vs naturalistic studies.
    Fagiolini A; Rocca P; De Giorgi S; Spina E; Amodeo G; Amore M
    Psychiatry Res; 2017 Jan; 247():257-264. PubMed ID: 27936437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Series: Pragmatic trials and real world evidence: Paper 4. Informed consent.
    Kalkman S; van Thiel GJMW; Zuidgeest MGP; Goetz I; Pfeiffer BM; Grobbee DE; van Delden JJM;
    J Clin Epidemiol; 2017 Sep; 89():181-187. PubMed ID: 28502809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pragmatic design in randomized controlled trials.
    Purgato M; Barbui C; Stroup S; Adams C
    Psychol Med; 2015 Jan; 45(2):225-30. PubMed ID: 25065958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advancing nursing science through pragmatic trials.
    Finnegan L; Polivka B
    Nurs Outlook; 2018 Sep; 66(5):425-427. PubMed ID: 30126739
    [No Abstract]   [Full Text] [Related]  

  • 38. What we talk about when we talk about randomized controlled trials.
    Chetta A; Olivieri D
    Respiration; 2014; 87(1):9-10. PubMed ID: 24281333
    [No Abstract]   [Full Text] [Related]  

  • 39. Pragmatic randomized trials in drug development pose new ethical questions: a systematic review.
    Kalkman S; van Thiel GJ; Grobbee DE; van Delden JJ
    Drug Discov Today; 2015 Jul; 20(7):856-62. PubMed ID: 25794600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Not Available].
    Messori A
    Recenti Prog Med; 2019 Nov; 110(11):533. PubMed ID: 31808438
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.